Jeito Capital

News

Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.

News

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.